Octapharma AG made an offer to acquire 61.78% stake in SNP Schneider-Neureither & Partner SE (XTRA:SHF) for approximately €152 million on May 17, 2023. Octapharma AG has also entered into an agreement with a fund controlled by Petrus Advisers to acquire approximately 9.40% of the SNP Shares. The Bidder also intends to acquire Wolfgang Marguerre’s block of shares of approximately 28.83% prior to the completion of the Takeover Offer.

Both acquisitions will be made in connection with the Takeover Offer and will give the Bidder access to approximately 38.22% of the SNP Shares. The offer is subject to antitrust regulations. As of July 7, 2023.

The Board of Directors and the Managing Directors have come to the conclusion that the offer price of EUR 33.50 per share offered by the Bidder in the Offer Document is financially reasonable. Macquarie Capital Germany acted as financial advisor and fairness opinion provider to Board of Directors of SNP Schneider-Neureither & Partner SE.